DarioHealth Corp. Files 8-K
Ticker: DRIO · Form: 8-K · Filed: Jan 22, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Jan 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $25.6M |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
DarioHealth filed an 8-K on Jan 22 for an event on Jan 21. Check for updates.
AI Summary
DarioHealth Corp. filed an 8-K on January 22, 2025, reporting an event that occurred on January 21, 2025. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items. The company, formerly known as LabStyle Innovations Corp., is incorporated in Delaware and headquartered in New York.
Why It Matters
This 8-K filing signals a material event or update from DarioHealth Corp. to investors, potentially impacting its stock value.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- January 21, 2025 (date) — Earliest Event Reported
- January 22, 2025 (date) — Date of Report
- LabStyle Innovations Corp. (company) — Former Company Name
- New York (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by DarioHealth Corp. in this 8-K?
The filing indicates 'Other Events' as an item but does not specify the nature of these events within the provided text.
What financial statements or exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific contents are not detailed in the provided text.
When was DarioHealth Corp. formerly known as LabStyle Innovations Corp.?
The date of the name change from LabStyle Innovations Corp. to DarioHealth Corp. was November 1, 2011.
What is the principal executive office address for DarioHealth Corp.?
The principal executive offices are located at 18 W. 18th St, 5th Floor, New York, New York 10011.
What is the issuer's telephone number as listed in the filing?
The issuer's telephone number is 972 - 4-770-4055.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2025-01-22 16:04:03
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
- $25.6M — s release titled "DarioHealth Announces $25.6M Private Placement Positioning the Compa
Filing Documents
- tm254039d1_8k.htm (8-K) — 24KB
- tm254039d1_ex99-1.htm (EX-99.1) — 17KB
- 0001104659-25-005237.txt ( ) — 216KB
- drio-20250121.xsd (EX-101.SCH) — 3KB
- drio-20250121_lab.xml (EX-101.LAB) — 33KB
- drio-20250121_pre.xml (EX-101.PRE) — 22KB
- tm254039d1_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events . On January 21, 2025, DarioHealth Corp. (the "Company") issued a press release titled "DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025." A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits 99.1 Press release dated January 21, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 22, 2025 DARIOHEALTH CORP. By: /s/ Zvi Ben David Name: Zvi Ben David Title: Chief Financial Officer, Treasurer and Secretary